LGND - Ligand Pharmaceuticals Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$267.75
DETAILS
HIGH:
$289.00
LOW:
$252.00
MEDIAN:
$265.00
CONSENSUS:
$267.75
UPSIDE:
16.75%
SEC Filings
AI summaries extract footnotes, management discussion, and supplemental disclosures not found in the primary financial statements.
Summaries may contain errors.
Q1 2026
Available
FY 2025
Available
Q4 2025
Available
Q3 2025
Available
Q2 2025
Available
Q1 2025
Available
FY 2024
Available
Q4 2024
Available
Q3 2024
Available
Q2 2024
Available
Q1 2024
Available
FY 2023
Available
Q4 2023
Available
Q3 2023
Available
Q2 2023
Available
Q1 2023
Available
FY 2022
Available
Q4 2022
Available
Q3 2022
Available
Q2 2022
Available
Q1 2022
Available
FY 2021
Available
Q4 2021
Available
Q3 2021
Available
Q2 2021
Available
Q1 2021
Available
FY 2020
Available
Q4 2020
Available
Q3 2020
Available
Q2 2020
Available
Q1 2020
Available
FY 2019
Available
Q4 2019
Available
Q3 2019
Available
Q2 2019
Available
Q1 2019
Available
FY 2018
Available
Q4 2018
Available
Q3 2018
Available
Q2 2018
Available
Q1 2018
Available
FY 2017
Available
Q4 2017
Available
Q3 2017
Available
Q2 2017
Available
Q1 2017
Available